337 related articles for article (PubMed ID: 29110622)
21. Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition.
Ghorab MM; El-Gaby MSA; Alsaid MS; Elshaier YAMM; Soliman AM; El-Senduny FF; Badria FA; Sherif AYA
Anticancer Agents Med Chem; 2017; 17(10):1411-1425. PubMed ID: 28356021
[TBL] [Abstract][Full Text] [Related]
22. Anticancer and antiviral sulfonamides.
Scozzafava A; Owa T; Mastrolorenzo A; Supuran CT
Curr Med Chem; 2003 Jun; 10(11):925-53. PubMed ID: 12678681
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
Ghorab MM; Ragab FA; Hamed MM
Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
[TBL] [Abstract][Full Text] [Related]
24. Recent advances (2015-2016) in anticancer hybrids.
Kerru N; Singh P; Koorbanally N; Raj R; Kumar V
Eur J Med Chem; 2017 Dec; 142():179-212. PubMed ID: 28760313
[TBL] [Abstract][Full Text] [Related]
25. Coumarin derivatives with anticancer activities: An update.
Song XF; Fan J; Liu L; Liu XF; Gao F
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000025. PubMed ID: 32383190
[TBL] [Abstract][Full Text] [Related]
26. Exploring the PROTAC degron candidates: OBHSA with different side chains as novel selective estrogen receptor degraders (SERDs).
Li Y; Zhang S; Zhang J; Hu Z; Xiao Y; Huang J; Dong C; Huang S; Zhou HB
Eur J Med Chem; 2019 Jun; 172():48-61. PubMed ID: 30939353
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems.
Rostom SA
Bioorg Med Chem; 2006 Oct; 14(19):6475-85. PubMed ID: 16806944
[TBL] [Abstract][Full Text] [Related]
28. Antidiabetic effect of novel benzenesulfonylureas as PPAR-γ agonists and their anticancer effect.
Kharbanda C; Alam MS; Hamid H; Javed K; Dhulap A; Bano S; Ali Y
Bioorg Med Chem Lett; 2015 Oct; 25(20):4601-5. PubMed ID: 26384286
[TBL] [Abstract][Full Text] [Related]
29. Study of reactivity of cyanoacetohydrazonoethyl-N-ethyl-N-methyl benzenesulfonamide: preparation of novel anticancer and antimicrobial active heterocyclic benzenesulfonamide derivatives and their molecular docking against dihydrofolate reductase.
Debbabi KF; Al-Harbi SA; Al-Saidi HM; Aljuhani EH; Abd El-Gilil SM; Bashandy MS
J Enzyme Inhib Med Chem; 2016; 31(sup4):7-19. PubMed ID: 27557134
[TBL] [Abstract][Full Text] [Related]
30. Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers.
Ghorab MM; Alsaid MS; Al-Ansary GH; Abdel-Latif GA; Abou El Ella DA
Eur J Med Chem; 2016 Nov; 124():946-958. PubMed ID: 27770735
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and in vitro anticancer screening of some novel 4-[2-amino-3-cyano-4-substituted-5,6,7,8-tetrahydroquinolin-1-(4H)-yl]benzenesulfonamides.
Al-Said MS; Ghorab MM; Al-Qasoumi SI; El-Hossary EM; Noaman E
Eur J Med Chem; 2010 Jul; 45(7):3011-8. PubMed ID: 20413187
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and Evaluation of Some Dibromoquinazoline-sulphonamide Hybrids and some Schiff´s Base Analogs for their Cytotoxic Activity.
Ahmed MF; El-Haggar R
Anticancer Agents Med Chem; 2017 Nov; 17(11):1563-1569. PubMed ID: 28356022
[TBL] [Abstract][Full Text] [Related]
33. Sulphonamido-quinoxalines: search for anticancer agent.
Ingle R; Marathe R; Magar D; Patel HM; Surana SJ
Eur J Med Chem; 2013 Jul; 65():168-86. PubMed ID: 23708011
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines.
Mojzych M; Šubertová V; Bielawska A; Bielawski K; Bazgier V; Berka K; Gucký T; Fornal E; Kryštof V
Eur J Med Chem; 2014 May; 78():217-24. PubMed ID: 24681986
[TBL] [Abstract][Full Text] [Related]
35. Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties.
Kawai M; BaMaung NY; Fidanze SD; Erickson SA; Tedrow JS; Sanders WJ; Vasudevan A; Park C; Hutchins C; Comess KM; Kalvin D; Wang J; Zhang Q; Lou P; Tucker-Garcia L; Bouska J; Bell RL; Lesniewski R; Henkin J; Sheppard GS
Bioorg Med Chem Lett; 2006 Jul; 16(13):3574-7. PubMed ID: 16632353
[TBL] [Abstract][Full Text] [Related]
36. New analogues of the anticancer E7070: synthesis and pharmacology.
Laconde G; Pommery N; Depreux P; Berthelot P; Hénichart JP
J Enzyme Inhib Med Chem; 2003 Apr; 18(2):89-94. PubMed ID: 12943191
[TBL] [Abstract][Full Text] [Related]
37. Aromatase inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules.
Ghorab MM; Alsaid MS; Samir N; Abdel-Latif GA; Soliman AM; Ragab FA; Abou El Ella DA
Eur J Med Chem; 2017 Jul; 134():304-315. PubMed ID: 28427017
[TBL] [Abstract][Full Text] [Related]
38. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
[TBL] [Abstract][Full Text] [Related]
39. Sulfonamides as anticancer agents: A brief review on sulfonamide derivatives as inhibitors of various proteins overexpressed in cancer.
Elsayad KA; Elmasry GF; Mahmoud ST; Awadallah FM
Bioorg Chem; 2024 Jun; 147():107409. PubMed ID: 38714116
[TBL] [Abstract][Full Text] [Related]
40. The significance of N-methylpicolinamides in the development of anticancer therapeutics: Synthesis and structure-activity relationship (SAR) studies.
Moku B; Ravindar L; Rakesh KP; Qin HL
Bioorg Chem; 2019 May; 86():513-537. PubMed ID: 30782571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
